Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 30: 737-740, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spillman, T.
Right arrow Articles by Bretaudiere, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spillman, T.
Right arrow Articles by Bretaudiere, J. P.

Clinical Chemistry, Vol 30, 737-740, Copyright © 1984 by American Association for Clinical Chemistry

Removal of a component interfering with phosphatidylglycerol estimation in the "Helena" system for amniotic fluid phospholipids

T Spillman, DB Cotton, SC Lynn Jr and JP Bretaudiere

A simple " prechromatography " step removes a component of amniotic fluid ("pseudo PG") that otherwise co-chromatographs with phosphatidylglycerol in the system for amniotic fluid analysis developed by Touchstone et al. (Lipids 15: 61-62, 1980) and incorporated into the Helena "Fetal-Tek" kit. The final positions of the major phospholipids are practically unchanged but the faster migrating, more neutral components are swept into a tight band near the solvent front, providing improved general resolution. The resulting change in the ratio of "phosphatidylglycerol" to sphingomyelin ("PG"/S) is as much as 0.5 for some specimens, but no change is seen for others. In 20% of the 73 cases examined, including four of the six fluids associated with respiratory distress syndrome, the PG initially reported was found to be "pseudo PG" and was completely removed by the prechromatography step. This step produces a negligible decrease in the lecithin to sphingomyelin (L/S) ratio in amniotic fluid.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.